Numan, a UK-based digital healthcare support platform, has secured a $60 million (£44.7 million) investment, extending its Series B round. The new funding comes following a period of strong growth for the firm, which recently doubled its revenue to $90 million.
The company’s digital health platform provides users with clinician consultations, behavioural health coaching and medication prescriptions, along with access to an app that enables them to track progress and manage treatments.
Chief executive Sokratis Papafloratos said: “Our latest funding is a testament to both our commercial performance and belief in our long-term vision for providing personalised, preventative health at scale.”
“We are now perfectly positioned to expand our reach, deepen our clinical capabilities, and accelerate innovation to help our patients live happier, healthier, longer lives.”
The new funding package includes a $30 million (£22.4m) equity investment led by Big Pi Ventures, supported by Endeavor Catalyst, White Star Capital and Novator Partners. The fundraise also provides Numan with access to $27 million (£20.1 million) in growth capital from HSBC Innovation Banking.
Big Pi Ventures partner Nick Kalliagkopoulos said that the company had “demonstrated exceptional growth and a clear vision to tackle some of healthcare’s most pressing challenges, from obesity to hormonal health”.
He added: “The team’s focus on preventative care, patient engagement, and scalable technology sets Numan apart in the digital health sector. We’re confident that this infusion of capital will help Numan consolidate its leadership in the UK and pave the way for international expansion.”
